Thermo Fisher Scientific (TMO) Retained Earnings (2009 - 2026)

Thermo Fisher Scientific has disclosed Retained Earnings across 18 years of filings, most recently posting $60.6 billion for Q1 2026.

• Quarterly Retained Earnings rose 11.36% year-over-year to $60.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $60.6 billion (up 11.36% YoY) and the FY2025 annual result came in at -$2.4 billion, down 104.61% from the prior year.
• Retained Earnings advanced to $60.6 billion in Q1 2026, from -$2.4 billion in the prior quarter.
• Over five years, Retained Earnings peaked at $60.6 billion in Q1 2026 and troughed at -$3.1 billion in Q4 2022.
• A 5-year average of $24.9 billion and a median of $37.5 billion in 2022 frame the typical range for Retained Earnings.
• Annual changes were most pronounced in 2022 — Retained Earnings sank 108.64% — and 2025, when it jumped 2416.66%.
• Tracing TMO's Retained Earnings over 5 years: stood at -$3.1 billion in 2022, then surged by 1628.36% to $47.4 billion in 2023, then advanced by 12.11% to $53.1 billion in 2024, then tumbled by 104.61% to -$2.4 billion in 2025, then soared by 2576.8% to $60.6 billion in 2026.
• Business Quant data shows TMO's Retained Earnings at $60.6 billion in Q1 2026, -$2.4 billion in Q4 2025, and -$2.8 billion in Q3 2025.